Evidence map›Paper›PMID 36714647›Full record

ArticleFrontiers in pediatrics2022

A deep intronic splice variant of the

Pei Qian, Ying Bao, Hui-Mei Huang, Lei Suo, Yan Han, Zhi-Juan Li, Min Zhang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Genetic study of Alport syndrome in Tunisia.Pediatric nephrology (Berlin, Germany) · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Pei QianDepartment of Nephrology, Xi'an Children's Hospital, Xi'an, China.
Ying BaoDepartment of Nephrology, Xi'an Children's Hospital, Xi'an, China.
Hui-Mei HuangDepartment of Nephrology, Xi'an Children's Hospital, Xi'an, China.
Lei SuoDepartment of Nephrology, Xi'an Children's Hospital, Xi'an, China.
Yan HanDepartment of Nephrology, Xi'an Children's Hospital, Xi'an, China.
Zhi-Juan LiDepartment of Nephrology, Xi'an Children's Hospital, Xi'an, China.
Min ZhangDepartment of Nephrology, Xi'an Children's Hospital, Xi'an, China.
Xi’an Children’s Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: X-linked Alport syndrome (XLAS) is caused by pathogenic variants in Methods: The proband was a 5-year-old male with microscopic hematuria and a family history of renal disease in 5 relatives.His relatives had microhematuria with or without proteinuria. His maternal uncle developed renal failure at the age of 35 years. He was evaluated by renal biopsy,whole-exome sequencing (WES) and whole-genome sequencing (WGS) for Alport syndrome. RT-PCR and cDNA Sanger sequencing were performed on RNA extracted from the skin of the proband. Then, a splicing reporter minigene assay was used to examine the effect of the variation on the splicing of the primary transcript in transfected cells. Results: Pathological examination of the kidney of the proband revealed diffuse thinning of the glomerular basement membrane, and immunofluorescence analysis indicated normal expression of the Conclusion: This is the first report of the novel c.385-716G > A splicing mutation in the COL4A5 gene, which illustrates the importance of performing WGS to find additional mutations in WES-negative patients with highly suspected forms of genetic diseases. The same results obtained from the in-vitro and in-vivo splicing experiments confirm the consistency between the minigene assay and RT-PCR analysis. In addition, this study highlights the importance of functional analysis in diagnosis and genetic counseling in AS.

Indexed as

Alport syndromeCOL4A5minigeneRT-PCRsplice site mutationwhole-genome sequencing

Identifiers

PMID36714647
PMCPMC9880855
OpenAlexW4315650318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.